Learn everything you need to know about Guanfacine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

One of the main treatment challenges in alcohol use disorder (AUD) is the high rate of craving in combination with decreased cognitive functioning including impaired decision making and impulse ...

February 28, 2011 — The US Food and Drug Administration (FDA) has approved guanfacine extended-release tablets (Intuniv, Shire Plc) as adjunctive therapy to stimulants such as methylphenidate in the ...

Please provide your email address to receive an email when new articles are posted on . Extended-release guanfacine was safe and effective for short-term treatment of hyperactivity, impulsiveness and ...

Currently, no FDA-approved medication exists for the treatment of cocaine use disorder. Furthermore, as women become increasingly more at risk for the consequences of cocaine addiction, the need to ...

Oral use of guanfacine by children and adolescents newly diagnosed with attention-deficit/hyperactivity disorder (ADHD) increases corneal aberrations but does not ...

Apotex recalled three lots of Guanfacine, a drug used to treat ADHD, after finding one lot had trace amounts of a drug used to treat schizophrenia, bipolar disorder and depression. That medication is ...

FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents First once-daily nonstimulant to be ...

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that it has received an approvable letter from the US Food and Drug Administration (FDA) for INTUNIV (guanfacine) extended Shire announced ...

Contrary to popular belief, non-stimulant ADHD medications (atomoxetine and viloxazine) affect heart rate and blood pressure just as much as stimulants do. All ADHD medications except guanfacine ...